Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: A report of two cases

Clinical and Experimental Nephrology

Volumn 15, Issue 2, 2011, Pages 289-293

  Akimoto, Tetsu ^a   Otake, Toshiya ^a   Tanaka, Akira ^a   Takahashi, Hideaki ^a   Higashizawa, Toshihiko ^a   Inoue, Makoto ^a   Nishino, Katsuhiko ^a   Saito, Osamu ^a   Isoda, Norio ^a   Muto, Shigeaki ^a   Sugano, Kentaro ^a   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Corticosteroid; Hepatitis B virus reactivation; Lamivudine; Membranous nephropathy; Nephrotic syndrome

Indexed keywords

CANDESARTAN HEXETIL; COMPLEMENT COMPONENT C3C; DIPYRIDAMOLE; DIURETIC AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; IMMUNOGLOBULIN G; LAMIVUDINE; LOSARTAN POTASSIUM; MIZORIBINE; PREDNISOLONE; VIRUS DNA;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FEMALE; HEPATITIS B; HIP PAIN; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; LEG EDEMA; LEG SWELLING; LIVER FUNCTION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OSTEOARTHRITIS; PHYSICAL EXAMINATION; PROTEINURIA; SEROLOGY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

AGED; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LAMIVUDINE; MALE; PREDNISOLONE; RIBONUCLEOSIDES; TREATMENT OUTCOME;

EID: 79959201285     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0391-z     Document Type: Article

References (20)

1. Schwartz MM. Membranous nephropathy. In: Jennete JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall's pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 205-51.
2. Ponticelli C. Membranous nephropathy. J Nephrol. 2007;20: 268-87. (Pubitemid 47570357)
3. Lai KN, Tam JS, Lin HJ, Lai FMM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 1990;54:12-7. (Pubitemid 19284256)
4. Tang S, Lai FMM, Lui YH, Tang CCO, Kung NNS, Ho YW, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int. 2005;68:1750-8. (Pubitemid 43169919)
5. Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka Y, et al. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol. 2006;65:423-6. (Pubitemid 43853532)
6. Nishioka Y, Horita Y, Tadokoro M, Taura K, Suyama N, Miyazaki M, et al. Changing mizoribine administration from three divided dose to one single dose induced remission of relapsed membranous nephropathy. Nephrol Dial Transplant. 2006;21:2337-8. (Pubitemid 44295074)
7. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24:198-211. (Pubitemid 38456630)
8. Chuang TW, Hung CH, Huang SC, Lee CM. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy. J Formos Med Assoc. 2007;106:869-73.
9. Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis. 2006;65:983-9. (Pubitemid 44133258)
10. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136:699-712.
11. Lai KN, Li PKT, Lui SF, Au TC, Tam JSL, Tong KL, et al. Membranous nephropathy related to hepatitis B virus in adults. N Eng J Med. 1991;324:1457-63.
12. Chou CK, Wang LH, Lin HM, Chi CW. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells. Hepatology. 1992;16:13-8.
13. Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection. Can J Gastroenterol. 2005;19:625-9. (Pubitemid 41723288)
14. Okuse C, Yotsuyanagi H, Yamada H, Ikeda H, Takahashi H, Suzuki M, et al. Successful treatment of hepatitis B virus associated membranous nephropathy with lamivudine. Clin Nephrol. 2006;65:53-6. (Pubitemid 43091696)
15. Kannaan N, Horsmans Y, Goffin E. Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Clin Nephrol. 2006;65:208-10. (Pubitemid 43338000)
16. Mesquita M, Lasser L, Langlet P. Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis. Clin Nephrol. 2008;70:69-71. (Pubitemid 352005975)
17. Masuda T, Akimoto T, Ando Y, Kobayashi T, Meguro D, Muto S, et al. Changes in the urinary excretion of b2-microglobulin (b2MG) and N-acetyl- b-D-glucosaminidase (NAG) during treatment for lupus nephritis. Intern Med. 2008;47:287-90. (Pubitemid 351377292)
18. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-39. (Pubitemid 46374607)
19. Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akubulut H, et al. Lamivudine prophylaxis for prevention of chemotherapyinduced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepatitis. 2004;11:141-7. (Pubitemid 38365765)
20. Perma A, Chieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis. 2004;44:385-401. (Pubitemid 39164615)